0.00
0.00%
Close of 6 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Pressure Biosciences
Its shares trade under the ticker PBIO. It has been listed since 31 October 1996. In the fiscal year to 31 December 2023, it reported revenue of $2.0m and a net loss of $29.3m. At that date it held total assets of $1.0m and shareholders' equity of −$32.8m.
Pressure BioSciences, Inc. engages in the development, marketing, and sale of proprietary laboratory instrumentation and associated consumables. The company is headquartered in South Easton, Massachusetts. The firm's solutions are based on the properties of both constant and alternating, pressure cycling technology (PCT) hydrostatic pressure. Its PCT is an enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to reproducibly control bio-molecular interactions. Its primary focus is the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics and counter-bioterror applications. Its products include Barocyclers, Barocycler Accessories, External Pressure Calibration Device Kit, MicroTubes for Barocyclers, BaroShear K45, HUB High Pressure Generators and Accessories, HP Cell From ISS, and RF1700 Mini Ultra-High Pressure Pump.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Life Sciences Tools & Services
- Listed since
- 31 Oct 1996
- Employees
- 15
- Website
- pressurebiosciences.com ↗
Leadership
Pay as last reported
- Mr. Jeffrey PetersonIndependent Chairman of the Board$128,850
- Mr. Richard SchumacherPresident, Chief Executive Officer, Interim Chief Financial Officer, Treasurer, Clerk, Director, since 1978$375,891
- Dr. Edmund TingSenior Vice President - Engineering$227,357
- Dr. Alexander LazarevChief Science Officer$212,159
- Dr. Michael UrdeaIndependent Director$59,668
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Pressure BioSciences Inc develops PCT-based products for biomarker discovery and drug development in Health Care.
- The company's Barocyclers and BaroShear K45 are key products for biotherapeutics characterization and quality control.
- With 15 employees, the company maintains a focused team in Life Sciences Tools & Services sector.
Weaknesses
- Pressure BioSciences has only 15 employees, limiting scalability in the Health Care sector.
- The company's headquarters in South Easton, Massachusetts, may restrict market reach in global Health Care.
- Limited product range compared to larger competitors in Life Sciences Tools & Services.
Opportunities
- Expanding PCT technology into soil and plant biology applications offers new market opportunities.
- Growing demand for biotherapeutics characterization in the Health Care industry presents growth potential.
- Potential for international expansion in the Life Sciences Tools & Services sector globally.
Threats
- Competition from larger firms in the Health Care sector could impact market share.
- Rapid technological changes in Life Sciences Tools & Services may require significant R&D investment.
- Economic downturns affecting Health Care spending could reduce demand for PCT products.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.